August 26, 2013 12:56 pm
The inclusion of women, different racial and ethnic groups, and children is extremely important in clinical research to understand who is affected by a given disease or condition and to develop the appropriate treatments.
March 20, 2013 5:51 pm
Stanford bioethicist Hank Greely, JD, spoke out in an article in Nature exploring whether all these layers of approval are really still necessary.
March 7, 2013 12:19 pm
The vital role ESCROs have played in recent years can now be taken over by IRBs and IACUCs—both of which have existed at universities and research institutions for decades. Those two review bodies would only have to expand their remits slightly to cover hESC-specific considerations.
April 10, 2012 12:18 pm
In one of the first studies of its kind, University of Pennsylvania School of Nursing researchers have identified what cancer patients consider the “benefits and burdens” of participating in clinical research trials. From their findings, the researchers developed a model of the five elements of decision-making (physical, psychological, economic, familial, and social) that patients with cancer use to determine whether to participate or remain in a clinical trial.